Cargando…

Mesoamerican Nephropathy (MeN): What We Know so Far

In 2002, a report from El Salvador described a high incidence of chronic kidney disease (CKD) of unknown cause, mostly in young males from specific coastal areas. Similar situations were observed along the Pacific Ocean coastline of other Central American countries and southern Mexico (Mesoamerica)....

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez Polo, Vicente, Garcia-Trabanino, Ramon, Rodriguez, Guillermo, Madero, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588276/
https://www.ncbi.nlm.nih.gov/pubmed/33116757
http://dx.doi.org/10.2147/IJNRD.S270709
_version_ 1783600340367572992
author Sanchez Polo, Vicente
Garcia-Trabanino, Ramon
Rodriguez, Guillermo
Madero, Magdalena
author_facet Sanchez Polo, Vicente
Garcia-Trabanino, Ramon
Rodriguez, Guillermo
Madero, Magdalena
author_sort Sanchez Polo, Vicente
collection PubMed
description In 2002, a report from El Salvador described a high incidence of chronic kidney disease (CKD) of unknown cause, mostly in young males from specific coastal areas. Similar situations were observed along the Pacific Ocean coastline of other Central American countries and southern Mexico (Mesoamerica). This new form of CKD has been denominated Mesoamerican endemic nephropathy (MeN). The typical presentation of MeN is a young male from an endemic area with a family history of CKD, low eGFR, high serum creatinine, low level of albuminuria, hypokalemia, hyperuricemia, and urine urate crystals. Kidney biopsy demonstrating tubulointerstitial nephritis remains the gold standard for diagnosis but is available only for a minority. Commonly proposed causes include thermal stress/dehydration and/or exposure to environmental pollutants. However, likely, a third factor, which could be genetic or epigenetic, could contribute to the cause and development of the disease, along with social determinants. Currently, preventive measures focus on minimizing workers exposure to thermal stress/dehydration. There are many research opportunities and priorities should include clinical trials to evaluate the efficacy and safety of the current treatment protocols, along with etiological and genetic studies, and the development of kidney disease data systems. Although there is scant and controversial literature with regard s  to the etiology, diagnosis and management of the disease, our aim is to provide the reader a vision of the disease based on our experience.
format Online
Article
Text
id pubmed-7588276
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75882762020-10-27 Mesoamerican Nephropathy (MeN): What We Know so Far Sanchez Polo, Vicente Garcia-Trabanino, Ramon Rodriguez, Guillermo Madero, Magdalena Int J Nephrol Renovasc Dis Review In 2002, a report from El Salvador described a high incidence of chronic kidney disease (CKD) of unknown cause, mostly in young males from specific coastal areas. Similar situations were observed along the Pacific Ocean coastline of other Central American countries and southern Mexico (Mesoamerica). This new form of CKD has been denominated Mesoamerican endemic nephropathy (MeN). The typical presentation of MeN is a young male from an endemic area with a family history of CKD, low eGFR, high serum creatinine, low level of albuminuria, hypokalemia, hyperuricemia, and urine urate crystals. Kidney biopsy demonstrating tubulointerstitial nephritis remains the gold standard for diagnosis but is available only for a minority. Commonly proposed causes include thermal stress/dehydration and/or exposure to environmental pollutants. However, likely, a third factor, which could be genetic or epigenetic, could contribute to the cause and development of the disease, along with social determinants. Currently, preventive measures focus on minimizing workers exposure to thermal stress/dehydration. There are many research opportunities and priorities should include clinical trials to evaluate the efficacy and safety of the current treatment protocols, along with etiological and genetic studies, and the development of kidney disease data systems. Although there is scant and controversial literature with regard s  to the etiology, diagnosis and management of the disease, our aim is to provide the reader a vision of the disease based on our experience. Dove 2020-10-22 /pmc/articles/PMC7588276/ /pubmed/33116757 http://dx.doi.org/10.2147/IJNRD.S270709 Text en © 2020 Sanchez Polo et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Sanchez Polo, Vicente
Garcia-Trabanino, Ramon
Rodriguez, Guillermo
Madero, Magdalena
Mesoamerican Nephropathy (MeN): What We Know so Far
title Mesoamerican Nephropathy (MeN): What We Know so Far
title_full Mesoamerican Nephropathy (MeN): What We Know so Far
title_fullStr Mesoamerican Nephropathy (MeN): What We Know so Far
title_full_unstemmed Mesoamerican Nephropathy (MeN): What We Know so Far
title_short Mesoamerican Nephropathy (MeN): What We Know so Far
title_sort mesoamerican nephropathy (men): what we know so far
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588276/
https://www.ncbi.nlm.nih.gov/pubmed/33116757
http://dx.doi.org/10.2147/IJNRD.S270709
work_keys_str_mv AT sanchezpolovicente mesoamericannephropathymenwhatweknowsofar
AT garciatrabaninoramon mesoamericannephropathymenwhatweknowsofar
AT rodriguezguillermo mesoamericannephropathymenwhatweknowsofar
AT maderomagdalena mesoamericannephropathymenwhatweknowsofar